```html

Kernohan Notch Phenomenon

What is Kernohan notch phenomenon?

The Kernohan notch phenomenon is a rare neurological sign that occurs when a large intracranial mass (such as a tumor, hematoma, or swollen brain tissue) compresses the brainstem against the opposite side of the skull. This “secondary” compression creates a notch‑shaped indentation in the cerebral peduncle (the fiber bundle that carries motor signals from the brain to the spinal cord). Because the motor pathways are forced through this narrowed area, the patient may develop motor weakness on the same side of the body as the original lesion—an apparent “false‑localizing” sign that can confuse clinicians.

First described by Dr. Kernohan in the 1920s, the phenomenon is most often recognized on magnetic resonance imaging (MRI) or computed tomography (CT) scans as a focal depression (the “notch”) in the cerebral peduncle opposite the site of the primary mass effect. Clinically, it manifests as a paradoxical ipsilateral hemiparesis (weakness on the same side as the mass), contrary to the usual contralateral weakness expected from an intracranial lesion.

Understanding Kernohan notch phenomenon is crucial because it influences surgical planning, prognosis, and the interpretation of neuro‑imaging. Although it is an uncommon finding, recognizing it can prevent misdiagnosis of a second, separate lesion.

Common Causes

Any condition that produces a large, unilateral mass effect or rapid shift of brain structures can lead to Kernohan notch phenomenon. The most frequently reported causes include:

• Acute subdural hematoma – especially when the bleed is massive and causes rapid midline shift.
• Chronic subdural hematoma – slower accumulation can still produce enough pressure to deform the contralateral peduncle.
• Large intracerebral hemorrhage – usually lobar or basal ganglia bleeds that expand rapidly.
• Space‑occupying brain tumors – glioblastoma, meningioma, or metastases that occupy >2–3 cm in diameter.
• Severe cerebral edema – secondary to traumatic brain injury, massive stroke, or infection.
• Posterior fossa mass lesions – cerebellar tumors or hematomas that push the brainstem against the tentorial edge.
• Acute hydrocephalus with ventricular enlargement – can shift the brainstem laterally.
• Brain abscess – large, encapsulated infections can produce focal mass effect.
• Ischemic stroke with massive edema – especially large middle cerebral artery (MCA) infarcts.
• Severe traumatic brain injury – diffuse swelling combined with focal contusions.

Associated Symptoms

Because the phenomenon is essentially a by‑product of a larger intracranial process, patients often present with a constellation of symptoms related to the primary lesion, plus the paradoxical motor findings. Common associated signs include:

• Ipsilateral hemiparesis – weakness on the same side as the mass, which is the hallmark of Kernohan notch.
• Contralateral facial weakness – may coexist if the corticobulbar tract is also involved.
• Altered level of consciousness – ranging from drowsiness to coma, reflecting increased intracranial pressure (ICP).
• Headache – usually worsening over hours to days.
• Nausea and vomiting – especially if there is raised ICP.
• Pupillary changes – unilateral dilated or non‑reactive pupil from oculomotor nerve compression.
• Seizures – more common with cortical lesions or hemorrhage.
• Ataxia or gait disturbance – when posterior fossa structures are involved.
• Speech or language deficits – if dominant‑hemisphere cortex is affected.
• Visual field cuts – due to involvement of optic radiations or occipital lobe.

When to See a Doctor

Prompt medical attention can be lifesaving. Seek care immediately if you notice any of the following:

• Sudden, severe headache (“worst headache of my life”).
• Rapidly worsening weakness on one side of the body.
• New onset confusion, slurred speech, or difficulty understanding language.
• Vomiting that is not related to a gastrointestinal illness, especially if accompanied by headache.
• Loss of consciousness or a sudden change in alertness.
• Pupil that is unusually large, non‑reactive, or unequal.
• Seizure activity without a known seizure disorder.
• Any head injury followed by the above symptoms within 24 hours.

If you have a known brain tumor, chronic subdural collection, or recent neurosurgery and notice a new weakness or worsening headache, call your neurosurgeon or go to the emergency department right away.

Diagnosis

Diagnosing Kernohan notch phenomenon involves identifying both the primary mass‑effect lesion and the secondary peduncular indentation. The work‑up typically proceeds as follows:

1. Clinical Examination

• Neurological exam focusing on motor strength, cranial nerves, sensation, and coordination.
• Documentation of “false‑localizing” ipsilateral weakness, which raises suspicion.

2. Imaging Studies

• CT scan (non‑contrast) – rapid assessment for hemorrhage, acute mass effect, and midline shift.
• CT with contrast – helps delineate tumors or abscesses.
• MRI brain (T1, T2, FLAIR, DWI) – gold standard for visualizing the cerebral peduncle notch and characterizing the underlying lesion.
• Diffusion tensor imaging (DTI) – can map the integrity of corticospinal tracts, confirming compression.

3. Ancillary Tests

• Blood work: CBC, coagulation profile, electrolytes (useful for hemorrhage work‑up).
• Lumbar puncture – rarely indicated, only if infection or subarachnoid hemorrhage is suspected.
• Neuro‑physiology (EEG, evoked potentials) – occasionally used when seizures or cortical involvement are unclear.

4. Neuro‑Surgical Consultation

Any patient with suspected Kernohan notch requires a prompt neurosurgical evaluation to discuss potential decompression or lesion removal.

Treatment Options

Management focuses on relieving the primary cause of mass effect, which in turn resolves the secondary peduncular compression. Treatment strategies are tailored to the underlying condition.

Medical Management

• Intracranial pressure control – hyperosmolar therapy (mannitol or hypertonic saline), head‑of‑bed elevation, and controlled ventilation.
• Anticonvulsants – prophylactic levetiracetam or phenytoin in patients with hemorrhage or tumor.
• Corticosteroids – dexamethasone 4–10 mg IV/PO daily for vasogenic edema surrounding tumors or abscesses.
• Blood pressure management – keep systolic < 140 mmHg for hemorrhagic lesions (per AHA/ASA guidelines).
• Anticoagulation reversal – if a subdural/epidural hematoma is related to anticoagulant use.

Surgical Interventions

• Craniotomy or decompressive hemicraniectomy – to evacuate hematoma, remove tumor, or relieve edema.
• Ventriculostomy – external ventricular drain (EVD) for acute hydrocephalus.
• Stereotactic aspiration – for selected deep brain abscesses or cystic tumors.
• Endoscopic tumor resection – when feasible for intraventricular or colloid cysts.

Rehabilitation & Home Care

• Physical therapy to regain strength and balance once the acute phase has resolved.
• Occupational therapy for fine‑motor tasks and ADL (activities of daily living) retraining.
• Speech‑language therapy if cortical language areas were affected.
• Home safety modifications (grab bars, raised toilet seats) during recovery.
• Medication adherence – continue steroids taper, antiepileptics, and any disease‑specific drugs.

Prevention Tips

While Kernohan notch phenomenon itself cannot be prevented directly, reducing the risk of the underlying causes can lower the likelihood of developing it.

• Fall prevention – use handrails, remove tripping hazards, and wear protective gear, especially for older adults.
• Head injury protection – wear helmets when cycling, motorcycling, or participating in contact sports.
• Control hypertension – keep blood pressure within target ranges to lessen the risk of intracerebral hemorrhage.
• Manage anticoagulation responsibly – regular INR checks for warfarin, adhere to DOAC dosing, and discuss bleeding risk with your physician.
• Prompt treatment of infections – treat sinusitis, otitis media, or dental infections early to avoid brain abscess formation.
• Regular surveillance for known brain tumors – follow up imaging schedules recommended by oncology.
• Healthy lifestyle – balanced diet, regular exercise, and smoking cessation reduce overall stroke and tumor risk.
• Alcohol moderation – excessive alcohol increases bleed risk and impairs clotting.
• Early recognition of headache patterns – seek medical advice for new, persistent, or worsening headaches.

Emergency Warning Signs

Key Take‑aways

• Kernohan notch phenomenon is a “false‑localizing” sign where a large intracranial mass compresses the opposite cerebral peduncle, causing ipsilateral weakness.
• It is most commonly associated with massive subdural or intracerebral hemorrhages, large tumors, severe edema, or posterior fossa lesions.
• Prompt recognition, imaging, and neurosurgical evaluation are essential to address the primary mass effect.
• Management combines ICP control, specific medical therapy, and often surgical decompression.
• Preventive strategies focus on reducing the risk of head trauma, controlling vascular risk factors, and monitoring known brain lesions.

For personalized advice or if you suspect you have symptoms related to Kernohan notch phenomenon, please consult a neurologist or neurosurgeon without delay.

References: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, peer‑reviewed articles in *Journal of Neurosurgery* and *Neurocritical Care* (2020‑2024).

```